Recent information came to light that Ionis is still continuing pursue a drug for myotonic dystrophy. The first trial ended and was not successful. What we learned is that the team was impressed that progress was made. Rather than pursue this initial drug they may be switching to a new more highly improved drug. This makes sense as the cost to pursue a drug is high $$$$ and you want your best candidate forward.
1 thought on “Ionis Pharmaceuticals Pursuing More Potent Myotonic Dystrophy Drug”
Leave a Reply
You must be logged in to post a comment.
my Son and 3 Grandchildren have been diagnosed with this disease. Like to know if any form of treatment is being pursued.